RE: Patience22 Sep 2020 11:14
Sorry for such a long post, but I've been sitting on the outside for some time now...
I put my faith and money in Synairgen many months ago. In the early days we had lots of research data, including China’s excellent January trials with INF on its front line medical staff. Should any doubt remain look behind the so called ‘curtain’ and check out China’s collaboration with Cuba. Cuba has an impressive pharmaceutical record and is producing its own treatments.
Cuba has a population over 11m and its reported death tally for Covid19 stands at just 115. Their own treatment is ‘Cuban interferon alpha 2b’ developed over the last 30 years.
The SNG001 treatment is best used at the start of infection, so we’re all expecting the home trial results to be better than the hospital trials…. but my dilemma is how easily big pharma has managed to write off hydroxychloroquine, and are they doing the same with SNG001, for them it’s all about the vaccine. I don’t think it unreasonable to assume that individuals with the expertise and recognition required to peer review our results of nine weeks ago are in some way indebted to big pharma, hence no publication.
Since our results big pharma have tried to rescue their own therapeutic Remdesivir by prescribing it together with INF, although nowhere near as good as SGN001 it will have a positive effect.
All governments across the UN appear to be doing and saying the same thing, and seem unable to push therapeutics, only vaccines. The delay in getting SNG001 out into the market place is going to cost many many lives. How is the knowledge of SNG001 best put into the public domain? Maybe the embarrassment will force government to act sooner rather than later…
GLA & DYOR